Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer

Published: Jan 1, 2021
Abstract
Objective To determine the frequency of levothyroxine (LT4) supplementation after therapeutic lobectomy for low-risk differentiated thyroid cancer (DTC). Methods This retrospective cohort study enrolled adult patients with low-risk DTC confirmed using surgical pathology who underwent therapeutic lobectomy at a single institution from January 2016 through May 2020. The outcome measures were postoperative serum thyroid-stimulating hormone (TSH)...
Paper Details
Title
Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer
Published Date
Jan 1, 2021
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.